barr 200mg 588 (Didanosine 200 mg)

Pill imprint barr 200mg 588 has been identified as Didanosine 200 mg.

Didanosine is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for barr 200mg 588

Didanosine 200 mg barr 200mg 588 Front
Didanosine 200 mg barr 200mg 588 Back
Didanosine 200 mg barr 200mg 588
Didanosine
Imprint:
barr 200mg
588
Strength:
200 mg
Color:
Green & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00555-0588
Inactive Ingredients:
ferrosoferric oxide
croscarmellose sodium
D&C Yellow No. 10
aluminum oxide
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
gelatin
hydroxypropyl cellulose
hypromelloses
methacrylic acid
microcrystalline cellulose
polydextrose
polyethylene glycol
propylene glycol
shellac
silicon dioxide
sodium hydroxide
magnesium silicate
titanium dioxide
triacetin
triethyl citrate
D&C Red No. 33
FD&C Yellow No. 6
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
13411-0191 Advanced Pharmaceutical Services Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)